Haemonetics (HAE) Tops Q2 EPS by 18c, Revenues Beat; Raises FY20 EPS Guidance Above Consensus

November 1, 2019 6:10 AM

Haemonetics (NYSE: HAE) reported Q2 EPS of $0.87, $0.18 better than ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found